Physician profile
Robert Mclean
NPI 1558364398
$3,095.77
in general payments reported to CMS, 2019-2025
12 companies · $1,380 in 2025
The $1,380 reported for 2025 was more than what 85% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $47.01 · 2023: $89.45 · 2024: $1,471 · 2025: $1,380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,375 · Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,374.87 |
| Food and Beverage | $566.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,455.55 | 2024 | Inspira Air, Acclarent Aera |
| Inspire Medical Systems, INC. | $1,226.44 | 2023-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $145.08 | 2022-2025 | Dupixent, Libtayo |
| Acclarent, INC | $70.82 | 2021-2022 | |
| Medtronic, INC. | $65.48 | 2025 | Ligasure |
| Glaxosmithkline, LLC. | $27.89 | 2021 | |
| Stryker Corporation | $24.45 | 2021 | |
| Genzyme Corporation | $19.82 | 2023 | |
| Neurent Medical Limited | $17.47 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Cgg Medical INC | $15.91 | 2024 | |
| Alexion Pharmaceuticals, INC. | $15.53 | 2023 | Ultomiris |
| Optinose US, INC. | $11.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mclean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.